Aisling Capital Management as of Dec. 31, 2022
Portfolio Holdings for Aisling Capital Management
Aisling Capital Management holds 16 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bridgebio Pharma (BBIO) | 30.5 | $46M | 6.1M | 7.62 | |
| Verona Pharma Sponsored Ads (VRNA) | 23.0 | $35M | 1.3M | 26.13 | |
| Syndax Pharmaceuticals (SNDX) | 17.2 | $26M | 1.0M | 25.45 | |
| Monte Rosa Therapeutics (GLUE) | 7.4 | $11M | 1.5M | 7.61 | |
| Aclaris Therapeutics (ACRS) | 4.5 | $6.8M | 435k | 15.75 | |
| Biomea Fusion (BMEA) | 4.4 | $6.7M | 799k | 8.43 | |
| Poseida Therapeutics I (PSTX) | 3.7 | $5.5M | 1.0M | 5.30 | |
| Nuvation Bio Com Cl A (NUVB) | 3.2 | $4.9M | 2.5M | 1.92 | |
| Elevation Oncology (ELEV) | 1.8 | $2.7M | 2.8M | 0.95 | |
| Reneo Pharmaceuticals (RPHM) | 1.4 | $2.1M | 886k | 2.33 | |
| Spruce Biosciences (SPRB) | 0.9 | $1.3M | 1.2M | 1.10 | |
| Marker Therapeutics Ord | 0.6 | $849k | 3.1M | 0.27 | |
| Aeglea Biotherapeutics | 0.5 | $761k | 1.7M | 0.45 | |
| Avrobio Ord (AVRO) | 0.5 | $717k | 1.0M | 0.71 | |
| Viracta Therapeutics (VIRX) | 0.3 | $421k | 289k | 1.46 | |
| Atreca Cl A Com (BCEL) | 0.2 | $311k | 388k | 0.80 |
